Literature DB >> 7828730

Activation of an Asp-124-->Asn mutant of haloalkane dehalogenase by hydrolytic deamidation of asparagine.

F Pries1, J Kingma, D B Janssen.   

Abstract

Haloalkane dehalogenase hydrolyses various 1-halo-n-alkanes to the corresponding alcohols by covalent catalysis with formation of an alkyl-enzyme intermediate. The carboxylate function of the nucleophilic aspartate (Asp-124) that displaces the halogen during formation of the intermediate was changed to an amide by site-directed mutagenesis (Asp-124-->Asn). Activity measurements and analysis of peptides containing the nucleophilic residue showed that the mutant enzyme was inactive, but that the activity increased by rapid deamidation of the asparagine residue, yielding wild type enzyme. There was no indication for isoaspartate formation during this process. The results suggest that a water molecule that is located close to the carboxyl function of Asp-124 in the X-ray structure is highly reactive and is responsible for the observed deamidation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7828730     DOI: 10.1016/0014-5793(94)01420-6

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  4 in total

1.  A Ty1 reverse transcriptase active-site aspartate mutation blocks transposition but not polymerization.

Authors:  O Uzun; A Gabriel
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

2.  Functionally relevant motions of haloalkane dehalogenases occur in the specificity-modulating cap domains.

Authors:  Michal Otyepka; Jirí Damborský
Journal:  Protein Sci       Date:  2002-05       Impact factor: 6.725

3.  Involvement of Hat1p (Kat1p) catalytic activity and subcellular localization in telomeric silencing.

Authors:  Erica L Mersfelder; Mark R Parthun
Journal:  J Biol Chem       Date:  2008-08-26       Impact factor: 5.157

4.  Algorithms and semantic infrastructure for mutation impact extraction and grounding.

Authors:  Jonas B Laurila; Nona Naderi; René Witte; Alexandre Riazanov; Alexandre Kouznetsov; Christopher J O Baker
Journal:  BMC Genomics       Date:  2010-12-02       Impact factor: 3.969

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.